LAS VEGAS — In this video, Baruch D. Kuppermann, MD, PhD, of University of California, Irvine, discusses presentations on neovascular age-related macular degeneration at Clinical Trials at the Summit.
“In the future, with these drug delivery products, [patients] are going to have really extended benefit, so we’re going to have to figure out how often we should be seeing these patients,” Kuppermann told Healio. “It’s really a new paradigm that’s emerging out of these clinical trials, and we’re very excited by that.”